{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:36:16Z","timestamp":1774438576333,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Zhejiang Province","award":["no. LY19H060001"],"award-info":[{"award-number":["no. LY19H060001"]}]},{"name":"Zhejiang Province Project of the Science Technology Department","award":["no. 2015C37113"],"award-info":[{"award-number":["no. 2015C37113"]}]},{"name":"Zhejiang Traditional Chinese Medicine Science and Technology Plan Project","award":["no. 2022ZB093"],"award-info":[{"award-number":["no. 2022ZB093"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Thioacetamide (TAA) is used in various fields, such as synthetic drugs, organic chemical synthesis, and materials chemistry. TAA is mainly used to establish animal liver injury models and other organ damage models to explore their mechanisms for helping patients with liver disease. Liver damage can lead to abnormal expression of some enzymes in the serum, so we detected the appropriate enzyme levels in the serum of SD rats to verify the damage of TAA to the liver. More importantly, TAA caused bone damage is barely understood. Therefore, our research aims to establish a rat model reflecting the acute bone damage injury caused by TAA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The SD rats were intraperitoneally injected with normal saline (0.9%) or TAA (200\u2009mg\/kg, 400\u2009mg\/kg) for 1 month (once the other day). After the last intraperitoneal injection, serum samples from rats were used for biochemical tests. Masson staining is used to detect liver damage, and micro-CT is used to detect the changes in bone. Moreover, the three-point bending experiment was used to detect the force range of the hind limbs of SD rats.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared with the control group, after the intraperitoneal injection of TAA, the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), uric acid (UA), total bile acid (TBA), alkaline phosphatase (ALP), carbamide (UREA) and creatinine (CREA) rose sharply, while the levels of serum content of total protein (TP), lactate dehydrogenase (LDH), calcium (Ca) and phosphorus (P) were severely reduced. After TAA administration, collagen fibers were deposited and liver fibrosis was obvious. Micro-CT results showed that the bone surface, tissue surface, bone volume, and tissue volume of rats with an intraperitoneal injection of TAA were significantly reduced. In addition, the bones of rats with an intraperitoneal injection of TAA can resist less pressure and are prone to fractures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>TAA can cause liver damage in SD rats, which is explained by the changes in serum biochemical indicators and the deposition of liver collagen. More importantly, TAA can reduce bone mineral density and increase the separation of bone trabeculae in SD rats, and finally lead to bone injury. This suggests that TAA may become an ideal model to investigate abnormal bone metabolism after liver injury.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40360-022-00568-4","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T13:02:37Z","timestamp":1651928557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Acute bone damage through liver-bone axis induced by thioacetamide in rats"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaoli","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linyan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yetao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0163-506X","authenticated-orcid":false,"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"key":"568_CR1","first-page":"230","volume":"10","author":"National Toxicology Program","year":"2002","unstructured":"National Toxicology Program. Thioacetamide. Rep Carcinog. 2002;10:230\u20131.","journal-title":"Rep Carcinog"},{"issue":"2814","key":"568_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1126\/science.108.2814.626","volume":"108","author":"OG Fitzhugh","year":"1948","unstructured":"Fitzhugh OG, Nelson AA. Liver Tumors in Rats Fed Thiourea or Thioacetamide. Science. 1948;108(2814):626\u20138.","journal-title":"Science."},{"key":"568_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.pa.22.040182.001541","volume":"22","author":"RA Neal","year":"1982","unstructured":"Neal RA, Halpert J. Toxicology of thiono-sulfur compounds. Annu Rev Pharmacol Toxicol. 1982;22:321\u201339.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"568_CR4","first-page":"1877","volume":"33","author":"J Chilakapati","year":"2005","unstructured":"Chilakapati J, Shankar K, Korrapati MC, Hill RA, Mehendale HM. Saturation toxicokinetics of thioacetamide: role in initiation of liver injury. Drug Metab Dispos. 2005;33(12):1877\u201385.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"568_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jhep.2005.06.011","volume":"44","author":"V Pallottini","year":"2006","unstructured":"Pallottini V, Martini C, Bassi AM, Romano P, Nanni G, Trentalance A. Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content. J Hepatol. 2006;44(2):368\u201374.","journal-title":"J Hepatol"},{"issue":"2","key":"568_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s10620-009-0745-0","volume":"55","author":"HC Karantonis","year":"2010","unstructured":"Karantonis HC, Gribilas G, Stamoulis I, Giaginis C, Spiliopoulou C, Kouraklis G, et al. Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis. Dig Dis Sci. 2010;55(2):276\u201384.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"568_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jss.2013.08.016","volume":"186","author":"CH Shao","year":"2014","unstructured":"Shao CH, Chen SL, Dong TF, Chai H, Yu Y, Deng L, et al. Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats. J Surg Res. 2014;186(1):408\u201316.","journal-title":"J Surg Res"},{"issue":"2","key":"568_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nbt.2089","volume":"30","author":"SJ Patel","year":"2012","unstructured":"Patel SJ, Milwid JM, King KR, Bohr S, Iracheta-Vellve A, Li M, et al. Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol. 2012;30(2):179\u201383.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"568_CR9","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1038\/s41598-017-02798-7","volume":"7","author":"H Dweep","year":"2017","unstructured":"Dweep H, Morikawa Y, Gong B, Yan J, Liu Z, Chen T, et al. Mechanistic roles of microRNAs in hepatocarcinogenesis: A study of thioacetamide with multiple doses and time-points of rats. Sci Rep. 2017;7(1):3054.","journal-title":"Sci Rep"},{"issue":"9","key":"568_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/gut.27.9.1073","volume":"27","author":"JE Compston","year":"1986","unstructured":"Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut. 1986;27(9):1073\u201390.","journal-title":"Gut."},{"issue":"1","key":"568_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1053\/jhep.2001.20533","volume":"33","author":"S Rouillard","year":"2001","unstructured":"Rouillard S, Lane NE. Hepatic osteodystrophy. Hepatology. 2001;33(1):301\u20137.","journal-title":"Hepatology."},{"issue":"6","key":"568_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jhep.2005.05.034","volume":"43","author":"AR Moschen","year":"2005","unstructured":"Moschen AR, Kaser A, Stadlmann S, Millonig G, Kaser S, M\u00fchllechner P, et al. The RANKL\/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol. 2005;43(6):973\u201383.","journal-title":"J Hepatol"},{"issue":"11","key":"568_CR13","doi-asserted-by":"publisher","first-page":"81652","DOI":"10.1371\/journal.pone.0081652","volume":"8","author":"LG Orsini","year":"2013","unstructured":"Orsini LG, Pinheiro MM, Castro CH, Silva AE, Szejnfeld VL. Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C. PLoS One. 2013;8(11):81652.","journal-title":"PLoS One"},{"issue":"7","key":"568_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJMoa055218","volume":"354","author":"RD Jackson","year":"2006","unstructured":"Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669\u201383.","journal-title":"N Engl J Med"},{"issue":"5","key":"568_CR15","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.bone.2011.02.015","volume":"48","author":"J Iwamoto","year":"2011","unstructured":"Iwamoto J, Seki A, Sato Y, Matsumoto H, Takeda T, Yeh JK. Effect of vitamin K2 on cortical and cancellous bone mass and hepatic lipids in rats with combined methionine-choline deficiency. Bone. 2011;48(5):1015\u201321.","journal-title":"Bone."},{"issue":"2","key":"568_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000145830","volume":"118","author":"V Lassila","year":"1984","unstructured":"Lassila V, Virtanen P. Influence of experimental liver injury on rat blood and alveolar bone under stress. Acta Anat. 1984;118(2):116\u201321.","journal-title":"Acta Anat"},{"issue":"1\u20132","key":"568_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0027-5107(95)00169-7","volume":"352","author":"ET Mirkova","year":"1996","unstructured":"Mirkova ET. Activities of the rodent carcinogens thioacetamide and acetamide in the mouse bone marrow micronucleus assay. Mutat Res. 1996;352(1\u20132):23\u201330.","journal-title":"Mutat Res"},{"key":"568_CR18","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3389\/fphar.2020.01016","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Chen M, Zhao Y, Li M, Qin Y, Cheng S, et al. Advance in drug delivery for ageing skeletal muscle. Front Pharmacol. 2020;11:1016.","journal-title":"Front Pharmacol"},{"issue":"4449","key":"568_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/175257a0","volume":"175","author":"DN Gupta","year":"1955","unstructured":"Gupta DN. Production of cancer of the bile ducts with thioacetamide. Nature. 1955;175(4449):257.","journal-title":"Nature."},{"issue":"10","key":"568_CR20","first-page":"954","volume":"17","author":"RG Kleinfeld","year":"1957","unstructured":"Kleinfeld RG. Early changes in rat liver and kidney cells induced by thioacetamide. Cancer Res. 1957;17(10):954\u201362.","journal-title":"Cancer Res"},{"issue":"3","key":"568_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/jnr.10862","volume":"75","author":"T Saran","year":"2004","unstructured":"Saran T, Hilgier W, Urbanska EM, Turski WA, Albrecht J. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy. J Neurosci Res. 2004;75(3):436\u201340.","journal-title":"J Neurosci Res"},{"issue":"1","key":"568_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1439-0264.2000.00207.x","volume":"29","author":"A Al-Bader","year":"2000","unstructured":"Al-Bader A, Mathew TC, Khoursheed M, Asfar S, al-Sayer H, Dashti HM. Thioacetamide toxicity and the spleen: histological and biochemical analysis. Anat Histol Embryol. 2000;29(1):3\u20138.","journal-title":"Anat Histol Embryol"},{"issue":"4","key":"568_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1021\/tx049869b","volume":"18","author":"NJ Waters","year":"2005","unstructured":"Waters NJ, Waterfield CJ, Farrant RD, Holmes E, Nicholson JK. Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity. Chem Res Toxicol. 2005;18(4):639\u201354.","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"568_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jhep.2004.09.020","volume":"42","author":"H Okuyama","year":"2005","unstructured":"Okuyama H, Nakamura H, Shimahara Y, Uyama N, Kwon YW, Kawada N, et al. Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice. J Hepatol. 2005;42(1):117\u201323.","journal-title":"J Hepatol"},{"issue":"6","key":"568_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/hep.1840150621","volume":"15","author":"F Nozu","year":"1992","unstructured":"Nozu F, Takeyama N, Tanaka T. Changes of hepatic fatty acid metabolism produced by chronic thioacetamide administration in rats. Hepatology. 1992;15(6):1099\u2013106.","journal-title":"Hepatology."},{"issue":"1\u20133","key":"568_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0300-483X(95)03177-H","volume":"106","author":"L Fontana","year":"1996","unstructured":"Fontana L, Moreira E, Torres MI, Fern\u00e1ndez MI, R\u00edos A, S\u00e1nchez de Medina F, et al. Serum amino acid changes in rats with thioacetamide-induced liver cirrhosis. Toxicology. 1996;106(1\u20133):197\u2013206.","journal-title":"Toxicology."},{"issue":"6","key":"568_CR27","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.1002\/jcp.27616","volume":"234","author":"F Al-Hashem","year":"2019","unstructured":"Al-Hashem F, Al-Humayed S, Amin SN, Kamar SS, Mansy SS, Hassan S, et al. Metformin inhibits mTOR-HIF-1\u03b1 axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations. J Cell Physiol. 2019;234(6):9328\u201337.","journal-title":"J Cell Physiol"},{"issue":"2","key":"568_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.taap.2015.07.016","volume":"288","author":"ES Jeong","year":"2015","unstructured":"Jeong ES, Kim G, Shin HJ, Park SM, Oh JH, Kim YB, et al. Increased serum bile acid concentration following low-dose chronic administration of thioacetamide in rats, as evidenced by metabolomic analysis. Toxicol Appl Pharmacol. 2015;288(2):213\u201322.","journal-title":"Toxicol Appl Pharmacol"},{"key":"568_CR29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3389\/fphar.2017.00791","volume":"8","author":"YX Li","year":"2017","unstructured":"Li YX, Gong XH, Liu MC, Peng C, Li P, Wang YT. Investigation of Liver Injury of Polygonum multiflorum Thunb. in Rats by Metabolomics and Traditional Approaches. Front Pharmacol. 2017;8:791.","journal-title":"Front Pharmacol"},{"issue":"4","key":"568_CR30","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0168-8278(96)80167-X","volume":"24","author":"SN Diez-Fernandez","year":"1996","unstructured":"Diez-Fernandez SN, Cascales M. Intracellular calcium concentration impairment in hepatocytes from thioacetamide-treated rats. Implications for the activity of Ca (2+)-dependent enzymes. J Hepatol. 1996;24(4):460\u20137.","journal-title":"J Hepatol"},{"issue":"6","key":"568_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1753-4887.2012.00473.x","volume":"70","author":"E Takeda","year":"2012","unstructured":"Takeda E, Yamamoto H, Yamanaka-Okumura H, Taketani Y. Dietary phosphorus in bone health and quality of life. Nutr Rev. 2012;70(6):311\u201321.","journal-title":"Nutr Rev"},{"issue":"3","key":"568_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/00325481.1978.11714929","volume":"64","author":"MD Burke","year":"1978","unstructured":"Burke MD. Hepatic function testing. Postgrad Med. 1978;64(3):177\u201382 185.","journal-title":"Postgrad Med"},{"issue":"25","key":"568_CR33","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.3748\/wjg.15.3086","volume":"15","author":"MJ Tu\u00f1\u00f3n","year":"2009","unstructured":"Tu\u00f1\u00f3n MJ, Alvarez M, Culebras JM, Gonz\u00e1lez-Gallego J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol. 2009;15(25):3086\u201398.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"568_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000146299","volume":"127","author":"P Virtanen","year":"1986","unstructured":"Virtanen P, Lassila V. Influence of thioacetamide-provoked liver injury on female rat blood and alveolar bone under stress. Acta Anat. 1986;127(4):285\u20139.","journal-title":"Acta Anat"},{"issue":"4","key":"568_CR35","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00204-013-1191-5","volume":"88","author":"AK Nussler","year":"2014","unstructured":"Nussler AK, Wildemann B, Freude T, Litzka C, Soldo P, Friess H, et al. Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis. Arch Toxicol. 2014;88(4):997\u20131006.","journal-title":"Arch Toxicol"},{"issue":"6","key":"568_CR36","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1002\/hep.26466","volume":"58","author":"N Gua\u00f1abens","year":"2013","unstructured":"Gua\u00f1abens N, Monegal A, Cerd\u00e1 D, Mux\u00ed \u00c1, Gifre L, Peris P, et al. Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis. Hepatology. 2013;58(6):2070\u20138.","journal-title":"Hepatology."},{"issue":"2","key":"568_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/03008207.2017.1290085","volume":"59","author":"X Chen","year":"2018","unstructured":"Chen X, Wang Z, Duan N, Zhu G, Schwarz EM, Xie C. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59(2):99\u2013107.","journal-title":"Connect Tissue Res"},{"issue":"12","key":"568_CR38","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/j.1440-1746.1996.tb01843.x","volume":"11","author":"A Nakano","year":"1996","unstructured":"Nakano A, Kanda T, Abe H. Bone changes and mineral metabolism disorders in rats with experimental liver cirrhosis. J Gastroenterol Hepatol. 1996;11(12):1143\u201354.","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"568_CR39","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1053\/j.gastro.2010.02.016","volume":"138","author":"N Guanabens","year":"2010","unstructured":"Guanabens N, Cerda D, Monegal A, Pons F, Caballer\u00eda L, Peris P, et al. Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis. Gastroenterology. 2010;138(7):2348\u201356.","journal-title":"Gastroenterology."}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-022-00568-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-022-00568-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-022-00568-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T13:08:18Z","timestamp":1651928898000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-022-00568-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1186\/s40360-022-00568-4","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"3 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments in this study were conducted in accordance with the animal experiment guidelines of Zhejiang Chinese Medical University Laboratory Animal Research Center (Approval No: IACUC-20181029-11; Number of Animal Use Permit: SYXK (\u6d59) 2018\u20130012).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}